MDxHealth SA (MDXH)
Last updated: 2026-11-06 18:57:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
MDxHealth SA (MDXH) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $0.15, with a market capitalization of $14.92M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.14 to $4.82. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$14.92M | |
$0.15 | |
$131.70 | |
$0.14 | |
$0.15 | |
145.43K | |
6.32M | |
-- | |
$4.82 | |
$0.14 | |
-- | |
-- |
MDxHealth SA (MDXH) Stock Price Today
MDxHealth SA (MDXH) is currently trading at $0.15 as of 2026-11-06 18:55:00, up 0.66% ($0.00) from the previous close of $0.15
During today's regular trading session, MDXH has traded between $0.14 and $131.70, with a trading volume of 145.43K shares. The current price is near the lower end of today's range.
MDxHealth SA (MDXH) 7-Day Stock Price Change
Over the past seven days, MDxHealth SA (MDXH) moved from $0.19 to $0.15, representing a decline of 20.83% ($0.04).
The stock traded between $0.14 and $0.21 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 849.62 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
MDXH 52-Week Price Position
Position in Range: 0.2%
MDXH is currently trading at $0.15, placing it 0.2% of the way from its 52-week low of $0.14 to its 52-week high of $4.82. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is MDxHealth SA (MDXH)?
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
MDxHealth SA Information
| Employees | 364 |
| Exchange | NASDAQ |
| Company Website |
How to Buy MDxHealth SA (MDXH) Stock on MEXC
Eligible investors can buy real shares of MDxHealth SA (MDXH) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is MDxHealth SA (MDXH) stock price today?
2.Is MDXH stock going up or down today?
3.What is MDXH pre-market price?
4.What is MDXH after-hours price?
5.Is MDXH stock trading now?
6.Where does MDXH sit relative to its 52-week high and low?
7.What sector is MDxHealth SA in?
8.What is MDxHealth SA's market capitalization and where is it listed?
9.How is MDXH valued in terms of P/E ratio and EPS?
10.Does MDxHealth SA pay a dividend?
Explore More US Stocks
Search Stocks
MDXH Stock Calculator
Estimate the value between MDXH shares and USD.
MDXH Shares to USD
1.00 MDXH shares = 0.152 USD
Calculations are estimates based on the latest available price and are for reference only.



